BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15086319)

  • 1. Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.
    Pasi KJ; Collins PW; Keeling DM; Brown SA; Cumming AM; Dolan GC; Hay CR; Hill FG; Laffan M; Peake IR
    Haemophilia; 2004 May; 10(3):218-31. PubMed ID: 15086319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.
    Laffan M; Brown SA; Collins PW; Cumming AM; Hill FG; Keeling D; Peake IR; Pasi KJ
    Haemophilia; 2004 May; 10(3):199-217. PubMed ID: 15086318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
    Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
    Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of inherited von Willebrand disease in 2007.
    Federici AB; Mannucci PM
    Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
    Federici AB
    Haemophilia; 2008 Jan; 14 Suppl 1():5-14. PubMed ID: 18173689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
    Keeney S; Bowen D; Cumming A; Enayat S; Goodeve A; Hill M;
    Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menorrhagia and bleeding disorders in adolescent females.
    Halimeh S
    Hamostaseologie; 2012; 32(1):45-50. PubMed ID: 22127528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of von Willebrand disease in Iran.
    Cohan N; Karimi M
    Semin Thromb Hemost; 2011 Jul; 37(5):602-6. PubMed ID: 22102206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand's disease: clinical management.
    Federici AB; Castaman G; Thompson A; Berntorp E
    Haemophilia; 2006 Jul; 12 Suppl 3():152-8. PubMed ID: 16684011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women and von Willebrand disease: controversies in diagnosis and management.
    Kadir RA; Chi C
    Semin Thromb Hemost; 2006 Sep; 32(6):605-15. PubMed ID: 16977570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 von Willebrand disease: application of emerging data to clinical practice.
    Collins PW; Cumming AM; Goodeve AC; Lillicrap D
    Haemophilia; 2008 Jul; 14(4):685-96. PubMed ID: 18510569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand disease in the pediatric and adolescent population.
    Mikhail S; Kouides P
    J Pediatr Adolesc Gynecol; 2010 Dec; 23(6 Suppl):S3-10. PubMed ID: 20934894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Von Willebrand disease: from diagnosis to treatment].
    Fressinaud E; Meyer D
    Rev Prat; 2005 Dec; 55(20):2209-18. PubMed ID: 16519045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand disease. Little known bleeding disorder.
    Can Fam Physician; 2001 Jun; 47():1265. PubMed ID: 11421058
    [No Abstract]   [Full Text] [Related]  

  • 19. Von Willebrand disease: an important differential for menorrhagia.
    Brooks MV
    Adv Nurse Pract; 2006 Mar; 14(3):67-8. PubMed ID: 16548132
    [No Abstract]   [Full Text] [Related]  

  • 20. [Willebrand disease].
    Lequièvre V
    Rev Infirm; 2006; (122):22-4. PubMed ID: 16881452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.